ACTFAST: Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration. A multicenter, twelve-week treatment, single step titration, open-label study assessing the percentage of dyslipidemic high-risk patients achieving low density lipoprotein cholesterol (LDL-C) target with atorvastatin starting doses of 10 mg, 20 mg, 40 mg, and 80 mg
Latest Information Update: 10 Nov 2021
Price :
$35 *
At a glance
- Drugs Atorvastatin (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- Acronyms ACTFAST
- Sponsors Pfizer
- 04 Apr 2007 New trial record.